<?xml version='1.0' encoding='utf-8'?>
<document id="24507658"><sentence text="Retrospective evaluation of cotrimoxazole use as preventive therapy in people living with HIV/AIDS in Boru Meda Hospital."><entity charOffset="28-41" id="DDI-PubMed.24507658.s1.e0" text="cotrimoxazole" /></sentence><sentence text="Drug use evaluation is a performance improvement method that focuses on evaluating and improving drug use process to achieve optimal patient outcomes" /><sentence text=" Drug use evaluation helps in identifying, preventing or resolving actual and potential drug related problems" /><sentence text=" The objective of the study was to evaluate the use of cotrimoxazole as preventive therapy in people living with HIV/AIDS in Boru Meda Hospital, Northeast Ethiopia"><entity charOffset="55-68" id="DDI-PubMed.24507658.s4.e0" text="cotrimoxazole" /></sentence><sentence text="" /><sentence text="A retrospective drug use evaluation was conducted on patients' medical history records based on a validated drug use evaluation criteria according to the national guideline" /><sentence text=" Medical history records of 248 patients were selected using systematic sampling method" /><sentence text="" /><sentence text="The result showed that 49" /><sentence text="6% of the patients were at WHO clinical stage III at the start of cotrimoxazole preventive therapy"><entity charOffset="66-79" id="DDI-PubMed.24507658.s10.e0" text="cotrimoxazole" /></sentence><sentence text=" In this study, the use of cotrimoxazole preventive therapy was consistent with the guideline in the rationale for indication (97"><entity charOffset="27-40" id="DDI-PubMed.24507658.s11.e0" text="cotrimoxazole" /></sentence><sentence text="98%), dose (96" /><sentence text="77%), and its use despite the presence of contraindications (91" /><sentence text="93%)" /><sentence text=" Problems regarding drug-drug interaction were identified in 49" /><sentence text="59% of cases, and 20" /><sentence text="97% of patients discontinued cotrimoxazole preventive therapy due to different reasons"><entity charOffset="29-42" id="DDI-PubMed.24507658.s17.e0" text="cotrimoxazole" /></sentence><sentence text="" /><sentence text="In most patients cotrimoxazole preventive therapy was consistent with the national guideline regarding the rationale for indication, dose, discontinuation and its use in the presence of contraindications"><entity charOffset="17-30" id="DDI-PubMed.24507658.s19.e0" text="cotrimoxazole" /></sentence><sentence text="" /></document>